Investigation Into the Scar Reduction Potential of Prevascar (Interleukin-10)

Status:
Completed

Trial end date:
2006-11-01

Target enrollment:

Participant gender:

The purpose of this study was to investigate the scar-reducing properties of eight doses of intradermal Prevascar (IL-10).

Phase 2

Renovo